12 studies found for:    PARKINSON DISEASE 10
Show Display Options
Rank Status Study
1 Not yet recruiting The Effects of Exercise in Parkinson's Disease
Condition: Parkinson Disease 10
Interventions: Other: Active Exercise;   Other: Passive Exercise
2 Completed Parkinson's Disease Treatment With Coenzyme Q10
Condition: Parkinson's Disease
Intervention: Drug: Coenzyme Q10
3 Terminated
Has Results
Effects of Coenzyme Q10 (CoQ) in Parkinson Disease
Condition: Parkinson Disease
Interventions: Drug: Coenzyme Q10 with vitamin E;   Drug: placebo with vitamin E
4 Completed NINDS Parkinson's Disease Neuroprotection Trial of CoQ10 and GPI 1485
Condition: Parkinson Disease
Interventions: Drug: CoQ10;   Drug: GPI 1485
5 Completed Coenzyme Q10 as a Symptomatic Treatment in Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: Coenzyme Q10 Nanodispersion (Nanoquinone);   Drug: Placebo
6 Completed Effects of High-dose Coenzyme Q10 on Biomarkers of Oxidative Damage and Clinical Outcome in Parkinson Disease
Condition: Parkinson Disease
Intervention: Dietary Supplement: coenzyme q10
7 Enrolling by invitation Deep Brain Stimulation Follow-up After 10 Years
Condition: Parkinson's Disease
Intervention:
8 Recruiting Comparison of the Incidence of Dyskinesia in Parkinson`s Disease Who Were Treated With Amantadine or Dopamine Agonist
Condition: Parkinson`s Disease
Intervention:
9 Completed Dose Range Finding Study of BF2.649 Versus Placebo to Treat Excessive Daytime Sleepiness in Parkinson's Disease Patients
Conditions: Excessive Daytime Sleepiness;   Parkinson's Disease
Interventions: Drug: Placebo;   Drug: BF 2.649 5 mg;   Drug: BF 2.649 10 mg;   Drug: BF 2.649 20 mg;   Drug: BF 2.649 40 mg
10 Recruiting Sagene 2014 - Parkinson's Disease and Erectile Dysfunction
Conditions: Parkinson's Disease;   Erectile Dysfunction
Interventions: Drug: Selegiline;   Drug: Tadalafil
11 Completed A Study of Istradefylline (KW-6002) in Treating Patients With Parkinson's Disease on Levodopa
Condition: Parkinson's Disease
Intervention: Drug: Istradefylline (KW-6002)
12 Completed Trial to Evaluate the Pharmacokinetics, Safety, and Tolerability of Rotigotine in Healthy Korean Subjects
Condition: Parkinson's Disease
Interventions: Drug: Rotigotine;   Other: Placebo

Indicates status has not been verified in more than two years